REQUEST A DEMO
Total
USD $0.00
Search more companies

Vaxthera Zona Franca S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vaxthera Zona Franca S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Vaxthera Zona Franca S.A.S. is a company based in Colombia, with its head office in Medellin. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on September 23, 2021. It currently has a total number of 2 (2023) employees. Its’ total assets recorded a growth of 54.49%.

Headquarters
Carrera 63 No 49A - 31 Piso 1
Medellin; Antioquia;

Contact Details: Purchase the Vaxthera Zona Franca S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Vaxthera Zona Franca S.A.S. report to view the information.
Registered Capital:
Purchase the Vaxthera Zona Franca S.A.S. report to view the information.
Financial Auditors:
Purchase the Vaxthera Zona Franca S.A.S. report to view the information.
Incorporation Date:
September 23, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Vaxthera Zona Franca S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Total operating revenue
72.96%
Operating profit (EBIT)
42.87%
EBITDA
44.38%
Net Profit (Loss) for the Period
-43.95%
Total assets
54.49%
Total equity
33.33%
Return on Equity (ROE)
-12.66%
Quick Ratio
-0.37%
Cash Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?